Paper37535697
Defeating a superbug: A breakthrough in vaccine design against multidrug-resistant Pseudomonas aeruginosa using reverse vaccinology.
Fereshteh S and 5 others. PLoS One, 2023. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Defeating a superbug: A breakthrough in vaccine design against multidrug-resistant Pseudomonas aeruginosa using reverse vaccinology. Papers, record 37535697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37535697
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Defeating a superbug: A breakthrough in vaccine design against multidrug-resistant Pseudomonas aeruginosa using reverse vaccinology.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Epitopes, B-Lymphocyte | Major topic |
| Pseudomonas aeruginosa | Major topic |
| Humans | |
| Molecular Docking Simulation | |
| Vaccinology | |
| Toll-Like Receptor 4 | |
| Molecular Dynamics Simulation | |
| Epitopes, T-Lymphocyte | |
| Computational Biology | |
| Vaccines, Subunit |
Source PubMed
References77
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20934990 | High-throughput prediction of protein antigenicity using protein microarray data. | Bioinformatics | 2010 | https://conductscience.org/library/papers/20934990 | PubMed |
| 2 | 31068928 | Rational Design of a Chimeric Derivative of PcrV as a Subunit Vaccine Against Pseudomonas aeruginosa. | Front Immunol | 2019 | https://conductscience.org/library/papers/31068928 | PubMed |
| 3 | 36059030 | In silico designing of a novel epitope-based candidate vaccine against Streptococcus pneumoniae with introduction of a new domain of PepO as adjuvant. | J Transl Med | 2022 | https://conductscience.org/library/papers/36059030 | PubMed |
| 4 | 21029963 | Reverse vaccinology: developing vaccines in the era of genomics. | Immunity | 2010 | https://conductscience.org/library/papers/21029963 | PubMed |
| 5 | 25882169 | MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine. | Vaccine | 2015 | https://conductscience.org/library/papers/25882169 | PubMed |
| 6 | 12499312 | ConSurf: identification of functional regions in proteins by surface-mapping of phylogenetic information. | Bioinformatics | 2003 | https://conductscience.org/library/papers/12499312 | PubMed |
| 7 | 10931321 | Structure and function of bacterial outer membrane proteins: barrels in a nutshell. | Mol Microbiol | 2000 | https://conductscience.org/library/papers/10931321 | PubMed |
| 8 | 15608175 | CDD: a Conserved Domain Database for protein classification. | Nucleic Acids Res | 2005 | https://conductscience.org/library/papers/15608175 | PubMed |
| 9 | 15215442 | Protein structure prediction and analysis using the Robetta server. | Nucleic Acids Res | 2004 | https://conductscience.org/library/papers/15215442 | PubMed |
| 10 | 16335991 | Identification of an OprD homologue in Acinetobacter baumannii. | J Proteome Res | 2005 | https://conductscience.org/library/papers/16335991 | PubMed |
| 11 | 29524839 | The effect of in silico targeting Pseudomonas aeruginosa patatin-like protein D, for immunogenic administration. | Comput Biol Chem | 2018 | https://conductscience.org/library/papers/29524839 | PubMed |
| 12 | 29524546 | An in silico structural and physicochemical characterization of TonB-dependent copper receptor in A. baumannii. | Microb Pathog | 2018 | https://conductscience.org/library/papers/29524546 | PubMed |
| 13 | 21474644 | The Th17 pathway in cystic fibrosis lung disease. | Am J Respir Crit Care Med | 2011 | https://conductscience.org/library/papers/21474644 | PubMed |
| 14 | 17617608 | Blocking of the TLR5 activation domain hampers protective potential of flagellin DNA vaccine. | J Immunol | 2007 | https://conductscience.org/library/papers/17617608 | PubMed |
| 15 | 32799724 | The Peptidoglycan-associated lipoprotein Pal contributes to the virulence of Burkholderia mallei and provides protection against lethal aerosol challenge. | Virulence | 2020 | https://conductscience.org/library/papers/32799724 | PubMed |
| 16 | 30040210 | Solubilization, Folding, and Purification of a Recombinant Peptidoglycan-Associated Lipoprotein (PAL) Expressed in Escherichia coli. | Curr Protoc Protein Sci | 2018 | https://conductscience.org/library/papers/30040210 | PubMed |
| 17 | 27479659 | TepiTool: A Pipeline for Computational Prediction of T Cell Epitope Candidates. | Curr Protoc Immunol | 2016 | https://conductscience.org/library/papers/27479659 | PubMed |
| 18 | 16352820 | Role of the novel OprD family of porins in nutrient uptake in Pseudomonas aeruginosa. | J Bacteriol | 2006 | https://conductscience.org/library/papers/16352820 | PubMed |
| 19 | 29506924 | Killed but metabolically active Pseudomonas aeruginosa-based vaccine induces protective humoral- and cell-mediated immunity against Pseudomonas aeruginosa pulmonary infections. | Vaccine | 2018 | https://conductscience.org/library/papers/29506924 | PubMed |
| 20 | 32565239 | Identification of novel vaccine candidate against Salmonella enterica serovar Typhi by reverse vaccinology method and evaluation of its immunization. | Genomics | 2020 | https://conductscience.org/library/papers/32565239 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42566513 | ZPY-CpG-Ch, a broad coverage vaccine against Streptococcus pneumoniae. | Sci Adv | 2026 | https://conductscience.org/library/papers/42566513 | PubMed |
| 42045396 | Design of a novel proteome-derived scaffold presenting epitopes of Pseudomonas aeruginosa in native conformation. | Sci Rep | 2026 | https://conductscience.org/library/papers/42045396 | PubMed |
| 41030544 | Molecular detection of blaVIM and blaNDM in multidrug-resistant Pseudomonas aeruginosa from cancer and burn patients in Erbil, Iraq. | Front Microbiol | 2025 | https://conductscience.org/library/papers/41030544 | PubMed |
| 39452186 | Beyond Antibiotics: What the Future Holds. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/39452186 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| TLR1 | 7096 | PubTator's text mining | https://conductscience.org/library/genes/7096 | NCBI Gene |
| TLR2 | 7097 | PubTator's text mining | https://conductscience.org/library/genes/7097 | NCBI Gene |
| TLR4 | 7099 | PubTator's text mining | https://conductscience.org/library/genes/7099 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37535697
GET https://conductscience.org/api/papers/v1/37535697/references?page=2